A trial to learn how safe AZD9550 is in people with type 2 diabetes who are overweight or obese

Trial Identifier: D8460C00002
Sponsor: AstraZeneca
NCTID:: NCT06151964
Start Date: September 2023
Primary Completion Date: April 2025
Study Completion Date: April 2025
Condition: Liver, Pancreas & Gallbladder - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
AT Graz, AT, 8036
AT Vienna, AT, 1090
DE Magdeburg, DE, 39120
DE Neuss, DE, 41460
DE Neu-Ulm, DE, 89231
JP Fukuoka-shi, JP, 812-0025
JP Shinjuku-ku, JP, 160-0004
JP Suita-shi, JP, 565-0853
SE Uppsala, SE, 752 37